HSBC Holdings’s Halozyme HALO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.85M | Sell |
28,781
-53,542
| -65% | -$3.77M | ﹤0.01% | 1562 |
|
|
2025
Q4 | $5.58M | Buy |
82,323
+76,002
| +1,202% | +$5.11M | ﹤0.01% | 1159 |
|
|
2025
Q3 | $465K | Sell |
6,321
-3,781
| -37% | -$251K | ﹤0.01% | 2146 |
|
|
2025
Q2 | $522K | Buy |
10,102
+5,448
| +117% | +$310K | ﹤0.01% | 2138 |
|
|
2025
Q1 | $297K | Sell |
4,654
-4,961
| -52% | -$288K | ﹤0.01% | 2382 |
|
|
2024
Q4 | $462K | Buy |
9,615
+3,289
| +52% | +$169K | ﹤0.01% | 2230 |
|
|
2024
Q3 | $361K | Sell |
6,326
-4,497
| -42% | -$258K | ﹤0.01% | 2214 |
|
|
2024
Q2 | $566K | Sell |
10,823
-112,237
| -91% | -$4.92M | ﹤0.01% | 1918 |
|
|
2024
Q1 | $5M | Buy |
123,060
+22,959
| +23% | +$861K | ﹤0.01% | 1100 |
|
|
2023
Q4 | $3.7M | Buy |
100,101
+21,697
| +28% | +$817K | ﹤0.01% | 1261 |
|
|
2023
Q3 | $3.01M | Buy |
78,404
+20,346
| +35% | +$833K | ﹤0.01% | 1285 |
|
|
2023
Q2 | $2.1M | Sell |
58,058
-42,506
| -42% | -$1.45M | ﹤0.01% | 1419 |
|
|
2023
Q1 | $3.84M | Buy |
100,564
+16,442
| +20% | +$771K | ﹤0.01% | 1225 |
|
|
2022
Q4 | $4.79M | Buy |
84,122
+1,218
| +1% | +$62.4K | 0.01% | 1269 |
|
|
2022
Q3 | $3.28M | Buy |
82,904
+32,118
| +63% | +$1.42M | 0.01% | 1349 |
|
|
2022
Q2 | $2.23M | Sell |
50,786
-7,052
| -12% | -$305K | ﹤0.01% | 1534 |
|
|
2022
Q1 | $2.31M | Sell |
57,838
-5,002
| -8% | -$178K | ﹤0.01% | 1543 |
|
|
2021
Q4 | $2.54M | Buy |
62,840
+16,316
| +35% | +$609K | ﹤0.01% | 1577 |
|
|
2021
Q3 | $1.89M | Buy |
+46,524
| New | +$1.95M | ﹤0.01% | 1559 |
|
|
2020
Q4 | – | Sell |
-18,732
| Closed | -$497K | – | 3081 |
|
|
2020
Q3 | $497K | Buy |
+18,732
| New | +$522K | ﹤0.01% | 1947 |
|
|
2020
Q2 | – | Sell |
-10,362
| Closed | -$184K | – | 2740 |
|
|
2020
Q1 | $184K | Sell |
10,362
-2,745
| -21% | -$52.1K | ﹤0.01% | 2326 |
|
|
2019
Q4 | $234K | Sell |
13,107
-24,235
| -65% | -$420K | ﹤0.01% | 2720 |
|
|
2019
Q3 | $579K | Buy |
+37,342
| New | +$615K | ﹤0.01% | 2247 |
|
|
2019
Q2 | – | Sell |
-16,597
| Closed | -$267K | – | 2752 |
|
|
2019
Q1 | $267K | Buy |
16,597
+5,859
| +55% | +$94.9K | ﹤0.01% | 2404 |
|
|
2018
Q4 | $157K | Buy |
+10,738
| New | +$171K | ﹤0.01% | 2508 |
|
|
2017
Q1 | – | Sell |
-18,782
| Closed | -$186K | – | 2306 |
|
|
2016
Q4 | $186K | Buy |
+18,782
| New | +$206K | ﹤0.01% | 2540 |
|
Other funds holding HALO
VCM
VPM
HSBC Holdings's HALO Position: Q1 2026 in Review
HSBC Holdings reduced its Halozyme (HALO) stake by 65% in Q1 2026, selling an estimated $3.77M and leaving 28,781 shares worth $1.85M. The position accounts for ﹤0.01% of the portfolio, ranked #1562.
HSBC Holdings first reported a position in HALO in Q4 2016 and has held it in 26 quarters since. The position peaked at $5.58M in Q4 2025. 635 funds tracked by Wall St. Rank hold HALO as of Q1 2026.
- HSBC Holdings held 28,781 shares of Halozyme worth $1.85M as of Q1 2026.
- HSBC Holdings sold 53,542 Halozyme shares in Q1 2026, an estimated $3.77M.
- Halozyme made up ﹤0.01% of HSBC Holdings's portfolio in Q1 2026, its #1562 holding.
- HSBC Holdings first reported a position in Halozyme in Q4 2016 and has held it in 26 quarters since.
- HSBC Holdings's Halozyme position peaked at $5.58M in Q4 2025.
- 635 funds tracked by Wall St. Rank held Halozyme as of Q1 2026.
Based on HSBC Holdings's 13F filing for Q1 2026, filed 30 Apr 2026.